gastrointestinal complications of iron supplement in pregnant wome
Not Applicable
- Conditions
- Condition 1: Normal pregnancy. Condition 2: Iron supplementation in pregnant women.Supervision of normal pregnancy-
- Registration Number
- IRCT138807182558N1
- Lead Sponsor
- Tarbiat modarres university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 139
Inclusion Criteria
age 17-35, Hb>13.2 gr/dl in 13- 18 W of gestation, single gestation, BMI=19.8 -26, no smoking and alcohol, appropriate nutrition, exclusion criteria: history or illness in heart disease. lung disease, kidney disease, gastro intestinal, thyroid, parathyroid, pancreas, diabetes mellitus, diabetes, gestational diabetes, lupus, chronic hypertension, epilepsy, viral infection, toxoplasmosis, STD, polycytemia vera, history and acute disease of malignancy, hyperemesis gravidarum, threatened abortion, bleeding in pregnancy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assesment of gastrointestinal side effects of Iron tablets. Timepoint: 24th and 36th weeks of gestation. Method of measurement: Questionnaire.
- Secondary Outcome Measures
Name Time Method